Clinical trial

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

NCT00003107

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1997-10-01

PhasePHASE1

Study timeline

Study start (unknown)1997-10-01Date precision: month

Registry last updated2014-09-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Chronic Myeloproliferative Disordersunresolved

Gestational Trophoblastic Tumorunresolved

Kidney Cancerunresolved

Leukemiaunresolved

Lymphomaunresolved

Multiple Myeloma and Plasma Cell Neoplasmunresolved

Myelodysplastic Syndromesunresolved

Neuroblastomaunresolved

Ovarian Cancerunresolved

Testicular Germ Cell Tumorunresolved

Interventions

recombinant interleukin-12BIOLOGICAL

Sponsors & collaborators

Indiana Universitylead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

IndianapolisIndiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00003107 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.